FAK inhibition using an oral small molecule inhibitor (VS-4718) resulted in a significant reduction in tumour fibrosis associated with a reduction in immunoinhibitory cell populations including granulocytes and myeloid-derived suppressor cells. This evidence concerns the gene PTK2 and neoplasm.